Literature DB >> 20837586

Heritability of apnea of prematurity: a retrospective twin study.

Elisabeth Bloch-Salisbury1, Mei Hua Hall, Priya Sharma, Theonia Boyd, Francis Bednarek, David Paydarfar.   

Abstract

BACKGROUND: Apnea of prematurity (AOP) is a disturbance in respiratory rhythm defined by idiopathic pauses in breathing that reduce blood oxygen levels and/or heart rate. It is a major clinical problem among preterm infants.
OBJECTIVES: The primary goal of this study was to estimate the genetic susceptibility to AOP in a cohort of preterm twins. A secondary aim was to identify risk factors associated with AOP in this cohort.
METHODS: A single-center, retrospective study (2000-2008) was performed by using data from 317 premature twin pairs (<36 weeks' gestational age). Heritability estimates were determined by comparing intrapair AOP concordance between 56 monozygotic and 161 dizygotic twin pairs by using structural equation modeling. Risk factors of AOP among a cohort of 543 premature twins were assessed by using mixed-effects logistic regression.
RESULTS: The heritability of AOP was 87% (95% confidence interval [CI]: 0.64-0.97) among same-gender twins. A gender-dependent model revealed that genetic factors accounted for 99% of the variance in male twins (95% CI: 0.89-1.00) and 78% of the variance in female twins (95% CI: 0.49-0.94). Significant risk factors for AOP were low gestational age (P<.001), cesarean delivery (P=.017), and conception through assisted reproductive technologies (P=.008).
CONCLUSIONS: These findings suggest that AOP has an important genetic basis underlying this developmental-related disorder of respiratory control. Future genomic studies may provide information on pathophysiological mechanisms that underlie AOP.

Entities:  

Mesh:

Year:  2010        PMID: 20837586     DOI: 10.1542/peds.2010-0084

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  6 in total

Review 1.  [Recent research on gene polymorphisms related to caffeine therapy in preterm infants with apnea of prematurity].

Authors:  Jiang-Biao Xie; Xin-Zhu Lin
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-07-15

2.  Genetic and Environmental Influences on Retinopathy of Prematurity.

Authors:  J M Ortega-Molina; R Anaya-Alaminos; J Uberos-Fernández; A Solans-Pérez de Larraya; M J Chaves-Samaniego; A Salgado-Miranda; R Piñar-Molina; A Jerez-Calero; J L García-Serrano
Journal:  Mediators Inflamm       Date:  2015-05-21       Impact factor: 4.711

Review 3.  Immature control of breathing and apnea of prematurity: the known and unknown.

Authors:  Grant Erickson; Nicole R Dobson; Carl E Hunt
Journal:  J Perinatol       Date:  2021-03-12       Impact factor: 2.521

Review 4.  Treating Apnea of Prematurity.

Authors:  Joseph Pergolizzi; Alexander Kraus; Peter Magnusson; Frank Breve; Kailyn Mitchell; Robert Raffa; Jo Ann K LeQuang; Giustino Varrassi
Journal:  Cureus       Date:  2022-01-31

5.  Caffeine Therapy for Apnea of Prematurity: Role of the Circadian CLOCK Gene Polymorphism.

Authors:  Hong-Li Guo; Jia-Yi Long; Ya-Hui Hu; Yun Liu; Xin He; Ling Li; Ying Xia; Xuan-Sheng Ding; Feng Chen; Jing Xu; Rui Cheng
Journal:  Front Pharmacol       Date:  2022-01-25       Impact factor: 5.810

6.  Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates.

Authors:  Tian Yu; Alfred H Balch; Robert M Ward; E Kent Korgenski; Catherine M T Sherwin
Journal:  BMC Pharmacol Toxicol       Date:  2016-06-07       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.